{"result": "(\"entity\"<|>GLUCOSE TRANSPORTER 1 DEFICIENCY SYNDROME<|>EVENT<|>Glucose Transporter 1 Deficiency Syndrome is a metabolic disorder that affects the transport of glucose into the brain, often treated with the ketogenic diet.)\n##\n(\"entity\"<|>CLASSICAL PHENOTYPE OF GLUCOSE TRANSPORTER 1 DEFICIENCY SYNDROME<|>EVENT<|>The classical phenotype of Glucose Transporter 1 Deficiency Syndrome is characterized by specific symptoms and is often treated with the ketogenic diet.)\n##\n(\"entity\"<|>PYRUVATE DEHYDROGENASE DEFICIENCY<|>EVENT<|>Pyruvate Dehydrogenase Deficiency is a metabolic disorder that can be treated with ketogenic diets, as indicated in various studies.)\n##\n(\"entity\"<|>KETOGENIC DIETS<|>EVENT<|>Ketogenic diets are dietary interventions that are high in fats and low in carbohydrates, used to manage various medical conditions, including epilepsy.)\n##\n(\"entity\"<|>NEAL EG<|>PERSON<|>Neal EG is a researcher who has contributed to studies on the ketogenic diet and its effects on neurological disorders.)\n##\n(\"relationship\"<|>KETOGENIC DIET<|>GLUCOSE TRANSPORTER 1 DEFICIENCY SYNDROME<|>The ketogenic diet is used as a treatment for Glucose Transporter 1 Deficiency Syndrome, highlighting its therapeutic applications.<|>8)\n##\n(\"relationship\"<|>KETOGENIC DIET<|>CLASSICAL PHENOTYPE OF GLUCOSE TRANSPORTER 1 DEFICIENCY SYNDROME<|>The ketogenic diet is effective in managing the classical phenotype of Glucose Transporter 1 Deficiency Syndrome.<|>8)\n##\n(\"relationship\"<|>KETOGENIC DIET<|>PYRUVATE DEHYDROGENASE DEFICIENCY<|>The ketogenic diet is utilized in the treatment of Pyruvate Dehydrogenase Deficiency, demonstrating its versatility in metabolic disorders.<|>8)\n##\n(\"relationship\"<|>KETOGENIC DIET<|>KETOGENIC DIETS<|>The ketogenic diet is a specific type of ketogenic diet used for various medical conditions, including epilepsy and metabolic disorders.<|>9)\n##\n(\"relationship\"<|>NEAL EG<|>KETOGENIC DIET<|>Neal EG has conducted research on the ketogenic diet, contributing to its understanding and application in treating neurological disorders.<|>8)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ://www.ketodietcalculator.org/ketoweb/               17.  Klepper J, Diefenbach S, Kohlsch√ºtter A, Voit T.\n      KetoStart                                                             Effects of the ketogenic diet in the glucose trans-\n  5.  Kim DW, Kang HC, Park JC, Kim HD. Benefits of                         porter 1 deficiency syndrome. Prostaglandins Leu-\n      the nonfasting ketogenic diet compared with the                       kot Essent Fatty Acids. 2004 Mar;70(3):321-7.\n      initial  fasting    ketogenic      diet.   Pediatrics.    2004   18.  Rauchenzauner M, Klepper J, Leiendecker B, Luef\n      Dec;114(6):1627-30.                                                   G, Rostasy K, Ebenbichler C. The ketogenic diet in\n  6.  Kang HC, Chung DE, Kim DW, Kim HD. Early- and                         children with Glut1 deficiency syndrome and epi-\n      late-onset complications of the ketogenic diet for                    lepsy. J Pediatr. 2008 Nov;153(5):716-8.\n      intractable          epilepsy.         Epilepsia.         2004   19.  Gumus H, Bayram AK, Kardas F, Canpolat M,\n      Sep;45(9):1116-23.                                                    √áaƒülayan AO, Kumandas S,              et al. The Effects of\n  7.  Mady MA, Kossoff EH, McGregor AL, Wheless                             Ketogenic Diet on Seizures, Cognitive Functions,\n      JW, Pyzik PL, Freeman JM. The ketogenic diet:                         and Other Neurological Disorders in Classical Phe-\n      adolescents       can    do    it,  too.   Epilepsia.     2003        notype of Glucose Transporter 1 Deficiency Syn-\n      Jun;44(6):847-51.                                                     drome. Neuropediatrics. 2015 Oct;46(5):313-20.\n  8.  Kwiterovich PO, Vining EPG, Pyzik P, Skolasky R,                 20.  Wexler ID, Hemalatha SG, McConnell J, Buist NR,\n      Freeman JM. Effect of a high-fat ketogenic diet on                    Dahl HH, Berry SA, et al. Outcome of pyruvate de-\n      plasma levels of lipids, lipoproteins, and apolipo-                   hydrogenase        deficiency     treated    with    ketogenic\n      proteins       in    children.      JAMA.        2003       Aug       diets. Studies in patients with identical mutations.\n      20;290(7):912-20.                                                     Neurology. 1997 Dec;49(6):1655-61.\n  9.  Kang HC, Kim YJ, Kim DW, Kim HD. Efficacy and                    21.  Nordli D. The ketogenic diet: uses and abuses.\n      safety of the ketogenic diet for intractable child-                   Neurology. 2002 Jun 25;58(12 Suppl 7):S21-4.\n      hood     epilepsy:    Korean     multicentric     experience.    22.  Olpin SE. Implications of impaired ketogenesis in\n      Epilepsia. 2005 Feb;46(2):272-9.                                      fatty acid oxidation disorders. Prostaglandins Leu-\n10.   Maydell B V, Wyllie E, Akhtar N, Kotagal P, Powas-                    kot Essent Fatty Acids. 2004 Mar;70(3):293-308.\n      ki K, Cook K, et al. Efficacy of the ketogenic diet in           23.  Vining E. Ketogenic diet. En: Engel J, TA P, editors.\n      focal versus generalized seizures. Pediatr Neurol.                    Epilepsy:     A   Comprehensive        Textbook.      Philadel-\n      2001 Sep;25(3):208-12.                                                phia: Lippincott-Raven; 1998. p. 1339-44.\n11.   Kossoff EH, Zupec-Kania BA, Amark PE, Balla-                     24.  Nordli DR, Kuroda MM, Carroll J, Koenigsberger\n      ban-Gil KR, Christina Bergqvist AG, Blackford R,                      DY, Hirsch LJ, Bruner HJ, et al. Experience with the\n---\n                                                                                   Tema 22.     Epilepsia. Dietas cetog√©nicas           375\n\n\n\n     ketogenic       diet    in   infants.     Pediatrics.     2001     38.  Fuehrlein BS, Rutenberg MS, Silver JN, Warren\n     Jul;108(1):129-33.                                                      MW, Theriaque DW, Duncan GE, et al. Differential\n25.  Kinsman SL, Vining EP, Quaskey SA, Mellits D, Fre-                      metabolic effects of saturated versus polyunsatu-\n     eman JM. Efficacy of the ketogenic diet for intrac-                     rated fats in ketogenic diets. J Clin Endocrinol Me-\n     table seizure disorders: review of 58 cases. Epilep-                    tab. 2004 Apr;89(4):1641-5.\n     sia. 33(6):1132-6.                                                 39.  Neal EG, Zupec-Kania B, Pfeifer HH. Carnitine\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>KETOGENIC DIET<|>EVENT<|>The ketogenic diet is a high-fat, low-carbohydrate diet that has been studied for its effects on various medical conditions, particularly epilepsy in children.)\n##\n(\"entity\"<|>EPILEPSIA<|>EVENT<|>Epilepsia is a medical journal that publishes research related to epilepsy, including studies on the ketogenic diet.)\n##\n(\"entity\"<|>KOREAN MULTICENTRIC EXPERIENCE<|>EVENT<|>The Korean multicentric experience refers to a study or series of studies conducted in Korea regarding the efficacy and safety of the ketogenic diet for intractable childhood epilepsy.)\n##\n(\"entity\"<|>JAMA<|>ORGANIZATION<|>JAMA is a peer-reviewed medical journal that publishes original research, reviews, and opinion pieces in the field of medicine.)\n##\n(\"entity\"<|>PEDIATRICS<|>ORGANIZATION<|>Pediatrics is a medical journal that focuses on the health and medical care of infants, children, and adolescents.)\n##\n(\"entity\"<|>NEUROLOGY<|>ORGANIZATION<|>Neurology is a medical journal that publishes research related to the field of neurology, including studies on epilepsy and dietary interventions.)\n##\n(\"entity\"<|>PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS<|>ORGANIZATION<|>This journal publishes research on the role of fatty acids and their derivatives in health and disease, including studies on the ketogenic diet.)\n##\n(\"entity\"<|>KIM DW<|>PERSON<|>Kim DW is a researcher who has contributed to studies on the ketogenic diet and its effects on various medical conditions.)\n##\n(\"entity\"<|>KANG HC<|>PERSON<|>Kang HC is a researcher involved in studies related to the ketogenic diet and its applications in treating epilepsy.)\n##\n(\"entity\"<|>VINING EPG<|>PERSON<|>Vining EPG is a researcher who has published work on the ketogenic diet and its efficacy in treating seizure disorders.)\n##\n(\"relationship\"<|>KETOGENIC DIET<|>EPILEPSIA<|>The ketogenic diet is a subject of research published in the journal Epilepsia, which focuses on epilepsy treatments.<|>8)\n##\n(\"relationship\"<|>KETOGENIC DIET<|>KOREAN MULTICENTRIC EXPERIENCE<|>The Korean multicentric experience studies the efficacy of the ketogenic diet for childhood epilepsy, highlighting its clinical applications.<|>7)\n##\n(\"relationship\"<|>KETOGENIC DIET<|>JAMA<|>Research on the ketogenic diet has been published in JAMA, indicating its relevance in medical literature.<|>6)\n##\n(\"relationship\"<|>KETOGENIC DIET<|>PEDIATRICS<|>The ketogenic diet is discussed in the Pediatrics journal, emphasizing its importance in pediatric health.<|>6)\n##\n(\"relationship\"<|>KETOGENIC DIET<|>NEUROLOGY<|>The ketogenic diet is a topic of interest in the Neurology journal, which covers neurological disorders including epilepsy.<|>6)\n##\n(\"relationship\"<|>KETOGENIC DIET<|>PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS<|>Research on the ketogenic diet's effects on fatty acid metabolism is published in this journal, linking dietary fats to health outcomes.<|>5)\n##\n(\"relationship\"<|>KIM DW<|>KETOGENIC DIET<|>Kim DW has conducted research on the ketogenic diet, contributing to its understanding and application in medical practice.<|>8)\n##\n(\"relationship\"<|>KANG HC<|>KETOGENIC DIET<|>Kang HC has published studies on the ketogenic diet, particularly its effects on epilepsy treatment.<|>8)\n##\n(\"relationship\"<|>VINING EPG<|>KETOGENIC DIET<|>Vining EPG has researched the ketogenic diet's efficacy in treating seizure disorders, contributing to the body of knowledge in this area.<|>8)\n<|COMPLETE|>"}]}